home / stock / bayry / bayry news


BAYRY News and Press, Bayer AG ADR From 05/14/24

Stock Information

Company Name: Bayer AG ADR
Stock Symbol: BAYRY
Market: OTC

Menu

BAYRY BAYRY Quote BAYRY Short BAYRY News BAYRY Articles BAYRY Message Board
Get BAYRY Alerts

News, Short Squeeze, Breakout and More Instantly...

BAYRY - Evercore says biotech 'winter is finally thawing'

2024-05-14 11:24:32 ET More on BioNTech, Moderna, etc. BioNTech SE 2024 Q1 - Results - Earnings Call Presentation BioNTech SE (BNTX) Q1 2024 Earnings Call Transcript Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks Moderna announces del...

BAYRY - Bayer Non-GAAP EPS of Euro2.82, revenue of Euro13.8B; currency-adjusted Group outlook confirmed

2024-05-14 02:17:11 ET More on Bayer AG Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News (Rating Downgrade) Bayer: Long-Term Upside After The Dividend Cut Bayer's shares jump after Monsanto wins appeal on PCB verdict Bayer dethroned as German...

BAYRY - AI-discovered drugs have an 80%-90% success rate: study

2024-05-10 14:13:46 ET More on Alphabet, Recursion, etc. Recursion Pharmaceuticals, Inc. (RXRX) Q1 2024 Earnings Call Transcript Bronte Capital - Alphabet: Could Not Find Anything We Liked More Google: The Recent Surge Is Far From Over CrowdStrike, Google exp...

BAYRY - Expected US Company Earnings on Thursday, May 9th, 2024

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

BAYRY - Elanco surges on Q1 beat, anticipated product launches

2024-05-08 11:48:27 ET More on Elanco Elanco Animal Health Incorporated 2024 Q1 - Results - Earnings Call Presentation Elanco Animal Health (ELAN) Q4 2023 Earnings Call Transcript Elanco Animal Health Incorporated 2023 Q4 - Results - Earnings Call Presentation ...

BAYRY - Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks

2024-05-06 09:50:37 ET Summary Regeneron is not having a great start to 2024 as the company missed Q1 revenue and EPS estimates and received two complete response letters from the FDA for odronextamab. First quarter results were negatively impacted by lower-than-expected collabora...

BAYRY - Regeneron falls after Q1 miss; announces $3B share buybacks

2024-05-02 07:55:40 ET More on Regeneron Pharmaceuticals Regeneron's Triple Threat: Eylea, Libtayo, And Dupixent Dominate Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript) Regeneron Pharmaceuticals, Inc. (REGN) Barclays ...

BAYRY - Bayer's shares jump after Monsanto wins appeal on PCB verdict

2024-05-02 07:17:58 ET More on Bayer Bayer AG (BAYZF) Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News (Rating Downgrade) Bayer: Long-Term Upside After The Dividend Cut Bayer dethroned as Germany’s top ...

BAYRY - Metagenomi, Moderna terminate gene editing collaboration

2024-05-01 16:56:15 ET More on Metagenomi, Inc. Stocks To Watch: Eyes On Broadcom, Target, Costco, Rivian And Small Caps Jefferies, BMO bullish on newly public Metagenomi Moderna-backed Metagenomi sees stock fall 31% after $94M IPO Historical earnings data fo...

BAYRY - Bayer goes ex dividend Monday

2024-04-26 14:35:34 ET More on Bayer Bayer AG (BAYZF) Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News (Rating Downgrade) Bayer: Long-Term Upside After The Dividend Cut Bayer dethroned as Germany’s top ...

Previous 10 Next 10